Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder

Journal of Cancer Research and Clinical Oncology

Volumn 130, Issue 2, 2004, Pages 122-125

  Birlik, M ^a   Akar, S ^a   Tuzel, E ^a   Onen, F ^a   Ozer, E ^a   Manisali, M ^a   Kirkali, Z ^a   Akkoc, N ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Chemotherapy; Gemcitabine; Vasculitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CISPLATIN; CREATININE; CYCLOPHOSPHAMIDE; GEMCITABINE; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; LACTATE DEHYDROGENASE; PREDNISOLONE;

ARTICLE; BLADDER CARCINOMA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DOPPLER FLOWMETER; ECHOGRAPHY; EDEMA; ELECTROPHYSIOLOGY; HUMAN; MYALGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RIGIDITY; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; VASCULITIS;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; DEOXYCYTIDINE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; URINARY BLADDER NEOPLASMS; URINARY DIVERSION; VASCULITIS;

EID: 1542283572     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-003-0529-4     Document Type: Article

References (16)

1. Aapro MS, Martin C, Hatty S (1998) Gemcitabine - a safety review. Anticancer Drugs 9:191-201
2. Voorburg AM, van Beek FT, Slee PH, Seldenrijk CA, Schramel FM (2002) Vasculitis due to gemcitabine. Lung Cancer 36:203-205
3. Niho S, Kubota K, Goto K, Ohmatsu H, Matsumoto T, Kakinuma R, et al (2002) Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study. Br J Cancer 87:1360-1364
4. Sanchez-Guerrero J, Gutierrez-Urena S, Vidaller A, Reyes E, Iglesias A, Alarcon-Segovia D (1990) Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature. J Rheumatol 17:1458-1462
5. Mallon E, Osborne G, Dinneen M, Lane RJ, Glaser M, Bunker CB (1999) Dermatomyositis in association with transitional cell carcinoma of the bladder. Clin Exp Dermatol 24:94-96
6. Bouropoulos C, Kanellakopoulou KD, Zarakovitis IE, Melekos MD (1997) Paraneoplastic polymyositis associated with transitional cell carcinoma of the bladder. J Urol 157:950-951
7. Ito H, Okafuji T, Suzuki T (1995) Vitamin E prevents endothelial injury associated with cisplatin injection into the superior mesenteric artery of rats. Heart Vessels 10:178-184
8. Fogarty G, Ball D, Rischin D (2001) Radiation recall reaction following gemcitabine. Lung Cancer 33:299-302
9. Ganem G, Solal-Celigny P, Joffroy A, Tassy D, Delpon A, Dupuis O (2000) Radiation myositis: the possible role of gemcitabine. Ann Oncol 11:1615-1616
10. Georgoulias V, Kouroussis C, Androulakis N, Kakolyris S, Dimopoulos MA, Papadakis E, et al (1999) Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial. J Clin Oncol 17:914-920
11. Tempero MA, Brand R (1998) Fatal pulmonary toxicity resulting from treatment with gemcitabine. Cancer 82:1800-1801
12. Dobbie M, Hofer S, Oberholzer M, Herrmann R. Venoocclusive disease of the liver induced by gemcitabine (1998) Ann Oncol 9:681
13. Banach MJ, Williams GA (2000) Purtscher retinopathy and necrotizing vasculitis with gemcitabine therapy. Arch Ophthalmol 118:726-727
14. Nackaerts K, Daenen M, Vansteenkiste J, Vandevelde A, Van Bleyenbergh P, Demedts M (1998) Hemolytic-uremic syndrome caused by gemcitabine. Ann Oncol 9:1355
15. Barcelo R, Lopez-Vivanco G, Mane JM, Rubio I, Munoz A, Fernandez R (2000) Distal ischemic changes related to combination chemotherapy with cisplatin and gemcitabine: description of four cases. Ann Oncol 11:1191-1194
16. Pavlakis N, Bell DR, Millward MJ, Levi JA (1997) Fatal pulmonary toxicity resulting from treatment with gemcitabine. Cancer 80:286-291